Building Tolerance Remotely: Telemedicine Support for Egg Ladder Completion in IgE ‐Mediated Egg Allergy

Key Points

• To evaluate the effectiveness of hybrid telemedicine for managing IgE-mediated egg allergy treatment.
• Hybrid telemedicine follow-up was compared to fully in-person care.
• Outcomes were assessed without additional in-person visits during COVID-19.
• Treatment continuity was monitored throughout the study period.
• Outcomes from telemedicine were comparable to in-person care.
• Duration and success of treatment were unaffected by the telemedicine approach.
• In-person visits decreased while maintaining treatment effectiveness.